He also discussed the use of fillers and toxins with laser and light devices. He highlighted that many of the new fillers, such as Belotero, are truly dermal fillers which can be damaged by some of our fractional laser and light devices. He also discouraged the concurrent use of Botox during the same visit where laser procedures are done and result in significant swelling. This could lead to a redistribution of toxin or Botox, as well as unwanted side effects.

Finally, in that same lecture, he presented a thorough discussion of photodynamic therapy. He pointed out that in the US only the treatment of AK is FDA approved. He also highlighted the use of this type of therapy for acne and skin cancers, such as superficial BCC and Bowens’ disease. In concluding, he discussed the usefulness of topical retinoids, such as Refissa, Re-Affirm and Tretinoin, for the treatment of sun-damaged skin. There is good scientific data to support their utility and an FDA approval for their use in the treatment of sun-damaged skin.

An arc lamp-based device providing optimized spectrum and pulse shape was characterized and compared with two pulsed dye laser (PDL) systems using a vascular phantom. Safety and effectiveness for facial telangiectasia are presented in
clinical case studies.

Please click the link to: Characterization of an Optimized Light Source and Comparison to Pulsed Dye Laser for Superficial and Deep Vessel Clearance

2011    

Robert A. Weiss, MD, E. Victor Ross, MD, Emil A. Tanghetti, MD, David B. Vasily, MD, James J. Childs, PhD, Mikhail Z. Smirnov, PhD, and Gregory B. Altshuler, PhD

This overview will explore the role of topical vitamin D in the skin, some
of the cellular pathways by which it works, topical psoriasis therapy,
and especially emerging research. The discussion will also focus in
on corticosteroids, vitamin D analogs, and combinations of topical
corticosteroids and vitamin D in the skin.

Please click the link to read more: Pathogenesis of Psorisis

2011

Emil A. Tanghetti, MD